Korean Research-based Pharma Industry Association (KRPIA) announced on Jan. 29 that it has appointed Oh Dong-wook, 51, CEO of Pfizer Korea, as its 14th chairman.
The new chairman will lead the KRPIA from next month. The term of office shall be two years, but may be extended by one year in accordance with the regulations.
Chairman Oh has gained experience by working for domestic and multinational pharmaceutical companies since 1994, and has been the CEO of Pfizer Pharmaceutical Korea since January 2016.
Previously, he worked in various fields such as marketing, sales and research in AstraZeneca Korea, MSD Korea, and Hanil Pharmaceutical.
Chairman Oh said, "We will speed up global expansion so that the pharmaceutical and bio industries can lead the innovative growth economy in the post-COVID-19 era," adding, "We will closely communicate with the government and domestic companies to create an ecosystem that can sustainably grow."
Founded in 1999, KRPIA is a group of multinational pharmaceutical companies operating in Korea, with a total of 44 member companies currently registered.